Q: How does Mexico fit into Auna’s broader regional footprint across Latin America, and what differentiates the Mexican market from Peru and Colombia?
A: Our core goal across Latin America is to transform regional healthcare. Auna originated in Peru with a highly consolidated, integrated ecosystem that encompasses hospitals, on-staff medical specialists, and an in-house health insurance provider.
In Colombia, the framework relies more heavily on public sector models and large-scale population agreements. Mexico, on the other hand, presents a diverse ecosystem with multiple distinct stakeholders: integrating insurance companies, physicians, and our hospital network to keep the patient strictly at the center of every clinical and operational decision.
Q: Private health insurance penetration in Mexico is relatively low while claims costs continue to rise. How has Auna adapted its prepaid and care models to local market dynamics without disrupting traditional insurer partnerships?
A: In Mexico, our specialized oncological plan is still relatively new compared to its 35-year track record in Peru, but it is gaining steady traction. On the hospital infrastructure side, we maintain strong strategic partnerships and agreements with all major insurance providers. We work collaboratively with insurers and medical teams to deliver high-quality, patient-safe care at the lowest possible cost.
Q: How is Auna leveraging its regional scale to deploy technologies such as clinical AI in Mexico?
A: Oncology is in Auna’s DNA, but we have expanded across all high-complexity specialties. At Doctors Hospital in Monterrey, for example, we recently inaugurated our new oncology center, equipped with state-of-the-art linear accelerators for radiotherapy.
These latest-generation systems incorporate clinical AI to assist physicians during treatment planning. For example, AI algorithms allow specialists to calculate precise tumor radiation parameters in minutes rather than days. Furthermore, the system dynamically adjusts to the patient’s body to target cancerous tissue directly, sparing surrounding healthy tissue. Every technological investment we make is driven by a commitment to sharper diagnostic accuracy and better patient outcomes.
Q: Beyond treating illness, Auna places a heavy emphasis on prevention. How do you measure the success of your preventive programs, and how are you shifting patient mindsets toward early intervention?
A: Our model extends beyond curing illness, aiming to provide continuous patient care and preventive health. We prioritize early detection because identifying diseases in their initial stages dramatically improves survival rates. In oncology, statistics demonstrate that up to 40% of cases can be mitigated or more effectively managed through timely intervention and healthier lifestyle awareness.
Shifting from reactive treatment to proactive prevention requires a cultural change that starts within families. Through our physician network, we promote regular health checkups and provide continuous post-treatment follow-up and rehabilitation outside the hospital. Most conventional private hospitals react only when an illness presents; Auna aims to transform Mexican healthcare by preventing illnesses in the first place.
For example, thanks to this integrated approach, our Oncosalud model has achieved a 75% five-year survival rate among its patients, a result comparable to those reported in countries with highly advanced oncology systems such as the United States, Canada, and the United Kingdom. This achievement has positioned Oncosalud as one of the leading regional benchmarks in cancer prevention, early detection, and treatment.
Q: Medical inflation consistently outpaces general economic inflation, creating financial pressures for insurers and families alike. What operational efficiencies or pricing strategies does Auna deploy to manage average claim costs?
A: The cost of pharmaceuticals is a key driver of medical inflation, largely due to the lack of standardized pricing. To mitigate this impact, we align providers, insurers, and physicians around shared value-based care and efficiency goals.
We focus on developing scalable operational models that keep quality high while driving down per-patient costs. Beyond private insurance policies, we offer transparent, fixed-price packages for out-of-pocket self-pay patients, ensuring financial predictability unless unexpected complications arise. We also establish public-private agreements, such as providing coverage for unionized and non-unionized civil servants in Nuevo Leon. Our target is broad accessibility rather than operating as a boutique niche hospital.
Q: Attracting and retaining top medical specialists is a key challenge, particularly in Northern Mexico. What is Auna’s value proposition to physicians?
A: Physicians are not merely service providers or clients to us; they are our core strategic partners in patient care. Our philosophy centers on establishing high-trust clinical environments.
We ensure our medical staff is fully supported across every touchpoint through fully equipped operating rooms, skilled nursing talent, and seamless administrative workflows. We also offer dedicated medical office towers adjacent to our hospital facilities. While we maintain a rigorous credentialing process to safeguard quality, we provide doctors with the volume, technology, and infrastructure required to build robust practices.
Q: Clinical research is increasingly crucial for top-tier hospital networks. How is Auna integrating clinical research into its regional operations?
A: Operating as an academic-oriented hospital network with active clinical research is fundamental to Auna’s mission. Research drives continuous clinical improvement and generates valuable medical knowledge across Latin America.
We operate cross-border tumor boards and clinical committees where oncologists and specialists from Mexico, Peru, and Colombia regularly collaborate to review complex cases and share best practices. This regional exchange elevates the standard of care across our entire network.
Q: What are Auna’s strategic expansion priorities for the Mexican market over the next three to five years?
A: Our priority in Mexico is expanding our high-volume, accessible care model into major metropolitan markets like Monterrey. Strategically, we are building specialized Centers of Excellence focused on four key high-complexity fields: oncology, cardiology, neurology, and traumatology/orthopedics. With our oncology center firmly established, we are accelerating development across the remaining three fields to deliver world-class, accessible care throughout Mexico.